The U.S. Food and Drug Administration (FDA) warned consumers not to use off-brand versions of weight-loss drugs Ozempic, Rybelsus, and Wegovy because they may not have the same ingredients. Those off-brand versions of the drugs are possibly unsafe or ineffective, ...